Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

Clinical trial NCT02526823 · UNKNOWN

Trial details

NCT number: NCT02526823
Sponsor: Shandong Provincial Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin;Hodgkin Disease

Start date: 2015-08-01
Primary completion: 2019-12-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.